Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Quantitative EBV viral loads and immunosuppression alterations can decrease PTLD incidence in pediatric liver

Timothy C Lee1, Barbara Savoldo, Cliona M Rooney

  • 1Michael E. DeBakey Department of Surgery, Baylor College of Medicine, Houston, Texas, USA.

American Journal of Transplantation : Official Journal of the American Society of Transplantation and the American Society of Transplant Surgeons
|August 13, 2005
PubMed
Summary

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Autoantigen-loaded Polymeric Microparticles associate with B cells and promote tolerogenic antigen presentation in a mouse model of experimental autoimmune encephalomyelitis.

Nature communications·2026
Same author

High-avidity cathepsin-G-specific CAR-T cells for the treatment of acute myeloid leukemia.

Blood·2026
Same author

Publisher Correction: Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026
Same author

Atlas-guided discovery of transcription factors for T cell programming.

Nature·2026
Same author

Infectious Complications Following CD30 Chimeric Antigen Receptor T-cell Therapy in Adults.

Open forum infectious diseases·2025
Same author

The landscape of CAR-engineered innate immune cells for cancer immunotherapy.

Nature cancer·2025
Same journal

Alpha-Gal Syndrome: Unrecognized Risks of a Tick-Bite-Associated Allergy in Transplantation and Cellular Therapy.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Comment on "Role of social determinants and outcomes of patients with alcohol-associated liver disease referred for early liver transplantation: A multicenter analysis".

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Ebola disease caused by Bundibugyo virus, Democratic Republic of the Congo & Uganda.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Donor Acute Kidney Injury Is Not Associated With Inferior Outcomes After Simultaneous Pancreas-Kidney Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

Human Biopsy-Defined IRI-Selective Reperfusion Signature Prioritizes Reperfusion-Timed MEK Inhibition After DCD Liver Transplantation.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
Same journal

OPERATIONAL TOLERANCE FOLLOWING INTESTINAL TRANSPLANTATION: A CASE REPORT WITH COMPREHENSIVE IMMUNE FOLLOW-UP FROM TRANSPLANT DAY TO THREE YEARS POST-IMMUNOSUPPRESSION WITHDRAWAL.

American journal of transplantation : official journal of the American Society of Transplantation and the American Society of Transplant Surgeons·2026
See all related articles
This summary is machine-generated.

Frequent Epstein-Barr virus (EBV) monitoring and tailored immunosuppression reduction significantly lowered post-transplant lymphoproliferative disorder (PTLD) in pediatric liver transplant recipients. This proactive approach is key to preventing PTLD in this vulnerable population.

Area of Science:

  • Pediatric Transplant Surgery
  • Virology
  • Immunology

Background:

  • Epstein-Barr virus (EBV) is a frequent infection in pediatric liver transplant recipients.
  • EBV infection can lead to the development of post-transplant lymphoproliferative disorder (PTLD).
  • Previous strategies for EBV management included immunosuppression reduction, antivirals, or IV CMV-immunoglobulin.

Purpose of the Study:

  • To evaluate the effectiveness of a protocol for frequent EBV monitoring.
  • To assess the impact of EBV viral load-driven immunosuppression reduction on PTLD incidence.
  • To determine if this protocol decreases PTLD in pediatric liver transplant patients.

Main Methods:

  • Prospective data collection from 2001-2004 at a single institution.

Related Experiment Videos

  • Comparison of a historical control group (pre-2001, 30 patients) with a treatment group (post-2001, 43 patients).
  • Implementation of frequent EBV viral load monitoring and immunosuppression tapering for EBV loads >4000 copies/microg DNA.

    • Main Results:

    • Eleven of 43 patients in the treatment group underwent immunosuppression tapering.
    • One patient experienced allograft rejection following immunosuppression modulation.
    • PTLD incidence decreased from 16% pre-protocol to 2% post-protocol (p<0.05).

    Conclusions:

    • Frequent EBV viral load monitoring is crucial in pediatric liver transplant recipients.
    • Preemptive immunosuppression modulation based on EBV viral load effectively prevents PTLD.
    • This protocol significantly reduces PTLD incidence in pediatric liver transplant patients.